Please use this identifier to cite or link to this item: http://hdl.handle.net/2067/38453
DC FieldValueLanguage
dc.contributor.authorCardona, F.en
dc.contributor.authorSilvestri, P.en
dc.contributor.authorBaglioni, V.en
dc.contributor.authorChillemi, Giovannien
dc.contributor.authorProsperini, G.en
dc.contributor.authorLionetto, L.en
dc.contributor.authorGentile, G.en
dc.contributor.authorSimmaco, M.en
dc.date.accessioned2020-10-20T23:01:41Z-
dc.date.available2020-10-20T23:01:41Z-
dc.date.issued2012en
dc.identifier.urihttp://hdl.handle.net/2067/38453-
dc.titlePharmacodynamic and pharmacogenetic assessment in TS patients treated with Aripiprazole. Preliminary resultsen
dc.typeconferenceObjecten
dc.relation.journal59th Annual Meetingen
dc.relation.conferencename59th Annual Meetingen
dc.type.miur273en
item.fulltextNo Fulltext-
item.openairetypeconferenceObject-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:D1. Contributo in Atti di convegno
Show simple item record

Page view(s)

62
Last Week
0
Last month
0
checked on Apr 17, 2024

Google ScholarTM

Check


All documents in the "Unitus Open Access" community are published as open access.
All documents in the community "Prodotti della Ricerca" are restricted access unless otherwise indicated for specific documents